Navigation Links
Lilly to host investment community meeting at its Indianapolis headquarters on Thursday, October 3, 2013
Date:9/30/2013

INDIANAPOLIS, Sept. 30, 2013 /PRNewswire/ --

WHAT:   Eli Lilly and Company (NYSE: LLY) will host a meeting for the investment community, including major long-term investors, sell-side analysts, financial media and ratings agency representatives.

WHEN:   The meeting will take place Thursday, Oct. 3, 2013.  The meeting will start at 8:30 a.m. (EDT) and last until approximately 12:30 p.m. (EDT).

WHO:     Company leaders will provide an in-depth update of its financial results, its pipeline progress, and its work to sustain a flow of innovative medicines over the long-term. There will be presentations by John C. Lechleiter, Ph.D., chairman, president, and chief operation officer; Derica Rice, chief financial officer; and Jan M. Lundberg, Ph.D., executive vice president of science and technology and president of Lilly Research Laboratories. Lilly's five business presidents also will highlight the significant opportunities in each of their areas. There will Q&A opportunities throughout the meeting.

WHERE:  Lilly's investment community meeting will take place at the company's global research and corporate headquarters in Indianapolis, IN.  

HOW:     A live webcast of the Lilly investment community meeting, along with presentation slides, will be available through a link on Lilly's website at www.lilly.com. The webcast will be available for replay over the next 12 months.

Media interested in attending in-person should contact Edward Sagebiel at (317) 985-6303 or Scott MacGregor at (317) 440-4699. Investors interested in attending should contact Lilly's investor relations department.

About Eli Lilly and Company
Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers – through medicines and information ─ for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com. F-LLY     

(Logo: http://photos.prnewswire.com/prnh/20031219/LLYLOGO )


'/>"/>
SOURCE Eli Lilly and Company
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Data Presented at 49th EASD Annual Meeting Show Treatment with Lillys Investigational Dulaglutide Resulted in Improved Patient-Reported Health Outcomes
2. Lilly Announces Second Positive Ramucirumab Phase III Gastric Cancer Study Meets Primary Endpoint; Phase III Lilly/TRIO Breast Cancer Study Misses Primary Endpoint
3. Exosome Diagnostics Enters Collaboration Agreement with Lilly for Exosome Blood-Based Biomarker Discovery
4. Lilly to Present Data Across its Diabetes Portfolio at the 49th European Association for the Study of Diabetes Annual Meeting
5. Humana and Lilly Form Research Collaboration to Improve Health Care Outcomes
6. Dr. Marschall S. Runge Elected to Lilly Board of Directors
7. Lilly Reports Second-Quarter 2013 Results
8. After Reviewing Brief Product Profiles, Surveyed Physicians Believe that Likely Candidates for Late-Phase Chronic Kidney Disease Products from AbbVie, Mitsubishi Tanabe, Eli Lilly, Concert, Fibrogen and Pfizer are Typically Stage 3b and 4 Patients
9. Lilly Disappointed in Draft Medicare Coverage Decision for Beta-Amyloid Imaging Agents
10. The Zacks Analyst Blog Highlights: Walgreens, Express Scripts Holding, Haemonetics, ResMed and Eli Lilly
11. Lilly Issues Alert for Illegal Scams Involving Fraudulent Checks and Online Job Requests
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... DIEGO , April 19, 2017  Sorrento ... an antibody-centric, clinical-stage biopharmaceutical company developing new treatments ... announced the closing of its previously announced underwritten ... stock at a public offering price of $2.00 ... and estimated offering expenses payable by Sorrento.  The ...
(Date:4/19/2017)... 19, 2017  Novartis today announced the publication ... Lung, and Blood Institute (NHLBI) of the National ... patients with treatment-naïve severe aplastic anemia (SAA) achieved ... eltrombopag at the initiation of and concurrently with ... three sequential treatment groups, or cohorts. Cohort 3 ...
(Date:4/18/2017)... 18, 2017 Cogentix Medical, Inc. (NASDAQ: CGNT), ... Urology, Uro/Gyn and Gynecology markets with innovative and proprietary ... ended March 31, 2017 after the market close on ... will host a conference call and webcast to discuss ... 2, 2017 at 4:30 p.m. Eastern Time (3:30 p.m. ...
Breaking Medicine Technology:
(Date:4/29/2017)... (PRWEB) , ... April 29, 2017 , ... ... Grocery Company to the list of fine retailers selling biodegradable, hanging flushable wipes ... H.E.B., a large supermarket chain headquartered in San Antonio, Texas, operates more than ...
(Date:4/28/2017)... ... April 28, 2017 , ... Accreditation Commission for Health Care ... of America (HCAOA). This agreement allows HCAOA members to receive special pricing on ... on Accreditation University (AU) educational resources that help prepare HCAOA members for ACHC ...
(Date:4/28/2017)... ... April 28, 2017 , ... Getting enough sleep affects much more than energy – ... just 19 hours without sleep can compromise motor reaction time, which can increase the risk ... Insurance is sharing the following tips from the NSF to help you sleep better and ...
(Date:4/28/2017)... ... April 28, 2017 , ... Datta Endoscopic Back ... joined the revolutionary endoscopic practice under Dr. Datta. Patel is a Board Certified ... The patented, revolutionary eDiscSculpt Technique created and used by Datta Endoscopic is unlike ...
(Date:4/28/2017)... MA (PRWEB) , ... April 28, 2017 , ... People ... for older people. “Wearing a hearing aid doesn’t have the stigma it had when ... & Hearing Associates of Greater Boston, in a NALA North American Speaker Series ...
Breaking Medicine News(10 mins):